NCT00748319
- Conditions
- Dermatitis, Dermatitis, Exfoliative, Disease, +18 more
- Locations
-
- Groupe hospitalier Henri Mondor - Albert Chenevier Créteil, France
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,045 public trials
2,032 recruiting studies
Lymphoproliferative Disorders trial results
Completed
Anti-Tac for Treatment of Leukemia
NCT00001941
- Conditions
- Deltaretrovirus Infections, Diabetes Mellitus, Insulin-Dependent, 10, HTLV-I Infection, +19 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
NCT00240565
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
NCT00038857
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +20 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00146055
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
NCT00535470
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Northwestern University-Dept. of Dermatology Chicago, Illinois, United States
- Columbia University, Dept of Dermatology New York, United States
- NYU Medical Center Dept. of Dermatology New York, United States
NCT00267059
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00476229
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States
NCT00071396
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
Completed
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
NCT00359892
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States